Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 13/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.70 |
| ▸ | MTOR | P42345 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Noraristeromycin SCHEMBL19644993 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| Noraristeromycin SCHEMBL8886019 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| Noraristeromycin SCHEMBL17109603 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| Noraristeromycin SCHEMBL1231088 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| Noraristeromycin SCHEMBL17117186 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| Noraristeromycin SCHEMBL29378522 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| Noraristeromycin SCHEMBL26381984 | 0.87 | AHCY (1.00) | AHCYADORA2B | |
| SCHEMBL12149495 | 0.85 | AHCY (0.86) | AHCYADORA2B | |
| SCHEMBL17302275 | 0.85 | AHCY (1.00) | AHCYADORA2B | |
| SCHEMBL26382107 | 0.85 | AHCY (1.00) | AHCYADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130023491-A1 | BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-01-24 | — | — | US | claimed |
| US-20130023491-A1 | BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023491-A1 | BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE | ADK, AHCY, IAPP | AHCY 2/4885ADORA2B 322/4885MTOR 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.